Probable RBD and association with neurodegenerative disease markers: A population-based study

Movement Disorders

Volumn 30, Issue 10, 2015, Pages 1417-1421

  Mahlknecht, Philipp ^a,b   Seppi, Klaus ^a   Frauscher, Birgit ^a   Kiechl, Stefan ^a   Willeit, Johann ^a   Stockner, Heike ^a   Djamshidian, Atbin ^a,c   Nocker, Michael ^a   Rastner, Verena ^a   Defrancesco, Michaela ^a   Rungger, Gregor ^d   Gasperi, Arno ^d   Poewe, Werner ^a   Högl, Birgit ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Hospital of Bruneck   (Italy)

Author keywords

Lewy body disease; Non motor symptom; Parkinson's disease; Probable REM sleep behavior disorder; Risk marker

Indexed keywords

AGED; ANXIETY; APATHY; ARTICLE; BECK DEPRESSION INVENTORY; COGNITION; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPOSMIA; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; NERVE DEGENERATION; NEUROPROTECTION; ODOR RECOGNITION TEST; PARASOMNIA; PARKINSON DISEASE; POLYSOMNOGRAPHY; PREVALENCE; PRIORITY JOURNAL; SALIVARY GLAND DISEASE; SELF REPORT; SUBSTANTIA NIGRA; VIVID DREAM; COHORT ANALYSIS; EUROPE; MIDDLE AGED; REM SLEEP BEHAVIOR DISORDER; VERY ELDERLY;

BIOLOGICAL MARKER;

AGED; AGED, 80 AND OVER; BIOMARKERS; COHORT STUDIES; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REM SLEEP BEHAVIOR DISORDER;

EID: 84941172430     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26350     Document Type: Article

References (33)

1. Boeve BF. Idiopathic REM sleep behaviour disorder in the development of Parkinson's disease. Lancet Neurol 2013;12:469-482.
2. Rolinski M, Szewczyk-Krolikowski K, Tomlinson PR, et al. REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease. J Neurol Neurosurg Psychiatry 2014;85:560-566.
3. Sixel-Döring F, Trautmann E, Mollenhauer B, Trenkwalder C. Associated factors for REM sleep behavior disorder in Parkinson disease. Neurology 2011;77:1048-1054.
4. Iranzo A, Tolosa E, Gelpi E, et al. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study. Lancet Neurol 2013;12:443-453.
5. Schenck CH, Boeve BF, Mahowald MW. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med 2013;14:744-748.
6. Postuma RB, Gagnon JF, Bertrand JA, Génier Marchand D, Montplaisir JY. Parkinson risk in idiopathic REM sleep behavior disorder: Preparing for neuroprotective trials. Neurology 2015;84:1104-1113.
7. Mahlknecht P, Iranzo A, Högl B, et al. for the SINBAR (Sleep Innsbruck Barcelona) Group. Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic REM-sleep behaviour disorder. Neurology 2015;84:654-658.
8. Iranzo A, Serradell M, Vilaseca I, et al. Longitudinal assessment of olfactory function in idiopathic REM sleep behavior disorder. Parkinsonism Relat Disord. 2013;19:600-604.
9. Frauscher B, Nomura T, Duerr S, et al. Investigation of autonomic function in idiopathic REM sleep behavior disorder. J Neurol 2012;259:1056-1061.
10. Gagnon JF, Vendette M, Postuma RB, et al. Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease. Ann Neurol 2009;66:39-47.
11. Postuma RB, Lang AE, Massicotte-Marquez J, Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 2006;66:845-851.
12. Stockner H, Iranzo A, Seppi K, et al. Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder. Mov Disord Mov Disord 2009;24:1906-1909.
13. Schenck CH, Montplaisir JY, Frauscher B, et al. Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy-a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group. Sleep Med 2013;14:795-806.
14. Mahlknecht P, Seppi K, Stockner H, et al. Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study. Neurodegener Dis 2013;12:212-218.
15. Mahlknecht P, Kiechl S, Bloem BR, et al. Prevalence and burden of gait disorders in elderly men and women aged 60-97 years: a population-based study. PLoS One 2013;8:e69627.
16. Stiasny-Kolster K, Mayer G, Schäfer S, et al. The REM sleep behavior disorder screening questionnaire: a new diagnostic instrument. Mov Disord 2007;22:2386-2393.
17. Frauscher B, Ehrmann L, Zamarian L, et al. Validation of the Innsbruck REM sleep behavior disorder inventory. Mov Disord 2012;27:1673-1678.
18. Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006;21:916-923.
19. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752.
20. Hummel T, Konnerth CG, Rosenheim K, Kobal G. Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol 2001;110:976-981.
21. Mahlknecht P, Stockner H, Nocker M, et al. A follow-up study of substantia nigra echogenicity in healthy adults. Mov Disord 2012;27:1196-1197.
22. Behnke S, Runkel A, Kassar HA, et al. Long-term course of substantia nigra hyperechogenicity in Parkinson's disease. Mov Disord 2013;28:455-459.
23. Iranzo A, Stockner H, Serradell M, et al. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder. Mov Disord 2014;29:1774-1780.
24. Ohayon MM, Caulet M, Priest RG. Violent behavior during sleep. J Clin Psychiatry 1997;58:369-376.
25. Chiu HF, Wing YK, Lam LC, et al. Sleep-related injury in the elderly: an epidemiological study in Hong Kong. Sleep 2000;23:513-517.
26. Kang SH, Yoon IY, Lee SD, Han JW, Kim TH, Kim KW. REM sleep behavior disorder in the Korean elderly population: prevalence and clinical characteristics. Sleep 2013;36:1147-1152.
27. Boot BP, Boeve BF, Roberts RO, et al. Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a population-based study. Ann Neurol 2012;71:49-56.
28. Frauscher B, Gabelia D, Mitterling T, et al. Motor events during healthy sleep: a quantitative polysomnographic study. Sleep 2014;37:763-773.
29. Stiasny-Kolstera K, Sixel-Döringc F, Trenkwalderc C, et al. Diagnostic value of the REM sleep behavior disorder screening questionnaire in Parkinson's disease. Sleep Med 2015;16:186-189.
30. Frauscher B, Jennum P, Ju YE, et al. Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study. Neurology 2014;82:1076-1079.
31. Postuma RB, Gagnon JF, Tuineaig M, et al. Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal? Sleep 2013;36:1579-1585.
32. Postuma RB, Aarsland D, Barone P, et al. Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease. Mov Disord 2012;27:617-626.
33. Berg D, Postuma RB, Bloem B, et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Mov Disord 2014;29:454-462.